Regeneron’s Covid mAb as a prophylactic injection: Reduced risk of symptomatic infection by 81%

Regeneron’s monoclonal antibody cocktail for Covid-19 continues to impress, this time in a joint trial with NIH that found the normally infused treatment works as a preventive subcutaneous injection.